Vandooren Jennifer, Born Benjamin, Solomonov Inna, Zajac Ewa, Saldova Radka, Senske Michael, Ugarte-Berzal Estefanía, Martens Erik, Van den Steen Philippe E, Van Damme Jo, Garcia-Pardo Angeles, Froeyen Matheus, Deryugina Elena I, Quigley James P, Moestrup Søren K, Rudd Pauline M, Sagi Irit, Opdenakker Ghislain
*Laboratory of Immunobiology, Rega Institute for Medical Research, University of Leuven, KU Leuven, B-3000 Leuven, Belgium.
†Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel.
Biochem J. 2015 Jan 15;465(2):259-70. doi: 10.1042/BJ20140418.
Gelatinase B/matrix metalloproteinase-9 (MMP-9) (EC 3.4.24.35) cleaves many substrates and is produced by most cell types as a zymogen, proMMP-9, in complex with the tissue inhibitor of metalloproteinases-1 (TIMP-1). Natural proMMP-9 occurs as monomers, homomultimers and heterocomplexes, but our knowledge about the overall structure of proMMP-9 monomers and multimers is limited. We investigated biochemical, biophysical and functional characteristics of zymogen and activated forms of MMP-9 monomers and multimers. In contrast with a conventional notion of a dimeric nature of MMP-9 homomultimers, we demonstrate that these are reduction-sensitive trimers. Based on the information from electrophoresis, AFM and TEM, we generated a 3D structure model of the proMMP-9 trimer. Remarkably, the proMMP-9 trimers possessed a 50-fold higher affinity for TIMP-1 than the monomers. In vivo, this finding was reflected in a higher extent of TIMP-1 inhibition of angiogenesis induced by trimers compared with monomers. Our results show that proMMP-9 trimers constitute a novel structural and functional entity that is differentially regulated by TIMP-1.
明胶酶B/基质金属蛋白酶-9(MMP-9)(EC 3.4.24.35)可切割多种底物,大多数细胞类型都以酶原形式(即前MMP-9)产生它,前MMP-9与金属蛋白酶组织抑制剂-1(TIMP-1)形成复合物。天然的前MMP-9以单体、同多聚体和异源复合物的形式存在,但我们对前MMP-9单体和多聚体的整体结构了解有限。我们研究了MMP-9单体和多聚体的酶原形式及活化形式的生化、生物物理和功能特性。与MMP-9同多聚体为二聚体性质的传统观念相反,我们证明这些是对还原敏感的三聚体。基于电泳、原子力显微镜和透射电子显微镜提供的信息,我们生成了前MMP-9三聚体的三维结构模型。值得注意的是,前MMP-9三聚体对TIMP-1的亲和力比单体高50倍。在体内,这一发现体现在与单体相比,三聚体诱导的血管生成受TIMP-1抑制的程度更高。我们的结果表明,前MMP-9三聚体构成了一种新型的结构和功能实体,受TIMP-1的差异调节。